OptimizeRx Corp (NAS:OPRX)
$ 10.48 -0.06 (-0.57%) Market Cap: 190.56 Mil Enterprise Value: 214.63 Mil PE Ratio: 0 PB Ratio: 1.50 GF Score: 78/100

OPTIMIZERx Corp at Bank of America Merrill Lynch Healthcare Conference (Virtual) Transcript

May 13, 2020 / 07:00PM GMT
Release Date Price: $9.77 (-1.61%)
Michael Aaron Cherny
BofA Merrill Lynch, Research Division - Director

Good afternoon, everyone, and thank you for joining this session of the BofA Securities Virtual Health Care Conference. I'm Michael Cherny, the health care tech and distribution analyst here at BofA. And it's my pleasure to have with us OptimizeRx on the phone with me today, unfortunately, not sitting on the stage in Las Vegas to do this fireside chat and presentation live, but we have Will Febbo, the Chief Executive Officer of OptimizeRx.

I think Will is going to go through a presentation, and then at the end, we'll probably address a few questions.

So with that, I will turn the stage over.

William J. Febbo
OptimizeRx Corporation - CEO & Director

Thanks, Mike.

And as Mike said, my name is Will Febbo. I'm the CEO and Director of OptimizeRx.

I just want to remind the audience to look at our safe harbor statement. It's prepared by OptimizeRx for information purposes only. I'll leave it to the audience to read through that.

More importantly

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot